Atranorin (Standard)

Atranorin (Standard) is the analytical standard of Atranorin (HY-N2907) . This product is intended for research and analytical applications. Atranorin is a secondary metabolite of lichens and AKT inhibitor. Atranorin possesses multiple activities such as antibacterial, anti-inflammatory, antioxidant, anti-glycation, analgesic, and anti-tumor effects. Atranorin has IC50 values for scavenging DPPH and ABTS free radicals of 117 μM and less than 10 μM, respectively. Additionally, Atranorin also exhibits effects in promoting wound healing. Atranorin can be used in the research of various diseases, including myelodysplastic syndromes, tumors, and inflammatory conditions[1][2].

Product Specifications

CAS Number

[479-20-9]

UNSPSC

12352005

Target

Akt; AP-1; Bacterial; Endogenous Metabolite; Fungal; PD-1/PD-L1; Ras; Reference Standards; STAT; Tim3; Wnt

Type

Reference Standards

Related Pathways

Anti-infection; GPCR/G Protein; Immunology/Inflammation; JAK/STAT Signaling; MAPK/ERK Pathway; Metabolic Enzyme/Protease; Others; PI3K/Akt/mTOR; Stem Cell/Wnt

Field of Research

Cancer; Infection; Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/atranorin-standard.html

Smiles

O=C(OC1=CC(C)=C(C(OC)=O)C(O)=C1C)C2=C(C)C=C(O)C(C=O)=C2O

Molecular Formula

C19H18O8

Molecular Weight

374.34

References & Citations

[1]Studzinska-Sroka E, et al. Atranorin - An Interesting Lichen Secondary Metabolite. Mini Rev Med Chem. 2017;17 (17) :1633-1645.|[2] Zhou R, et al. The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Sci Rep. 2017 Aug 15;7 (1) :8136.